Comparison of clinical prediction models for resistant bacteria in community-onset pneumonia

Academic Emergency Medicine

Volumn 22, Issue 6, 2015, Pages 730-740

  Self, Wesley H ^a   Wunderink, Richard G ^b   Williams, Derek J ^a   Barrett, Tyler W ^a   Baughman, Adrienne H ^a   Grijalva, Carlos G ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CARBAPENEM; CEFTRIAXONE; DOXYCYCLINE; LEVOFLOXACIN; LINEZOLID; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ALGORITHM; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; EMERGENCY WARD; FEMALE; GRAM NEGATIVE BACTERIUM; HEALTH CARE; HEALTH CARE ASSOCIATED PNEUMONIA; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; ANTIBIOTIC RESISTANCE; COMMUNITY ACQUIRED INFECTION; HOSPITAL EMERGENCY SERVICE; MIDDLE AGED; PNEUMONIA, BACTERIAL;

ADULT; AGED; ALGORITHMS; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; RETROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE;

EID: 84930760152     PISSN: 10696563     EISSN: 15532712     Source Type: Journal    
DOI: 10.1111/acem.12672     Document Type: Article

References (45)

1. Kung HC, Hoyert DL, Xu J, Murphy SL,. Deaths: final data for 2005. Natl Vital Stat Rep 2008; 56: 1-20.
2. Self WH, Grijalva CG, Zhu Y, et al., Rates of emergency department visits due to pneumonia in the United States, July 2006-June 2009. Acad Emerg Med 2013; 20: 957-60.
3. Agency for Healthcare Research and Quality. Pneumonia most common reason for hospitalization. Available at: http://archive.ahrq.gov/news/nn/nn070208.htm. Accessed Mar 10, 2015.
4. Mandell LA, Wunderink RG, Anzueto A, et al., Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 (Suppl 2): S27-72.
5. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
6. Niederman MS, Bass JB Jr, Campbell GD, et al., Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis 1993; 148: 1418-26.
7. American Thoracic Society. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995. Am J Respir Crit Care Med 1996; 153: 1711-25.
8. Friedman ND, Kaye KS, Stout JE, et al., Health care-associated bloodstream infection in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002; 137: 791-7.
9. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS,. Epidemiology and outcomes of health-care associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005; 128: 3854-62.
10. Muder RR, Aghababian RV, Loeb MB, Solot JA, Higbee M,. Nursing home-acquired pneumonia: an emergency department algorithm. Curr Med Res Opin 2004; 20: 1309-20.
11. Lobo LJ, Reed KD, Wunderink RG,. Expanded clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus pneumonia. Chest 2010; 138: 130-6.
12. Moran GL, Krishnadasan A, Gorwitz RJ, et al., Prevalence of methicillin-resistant Staphylococcus aureus as an etiology of community-acquired pneumonia. Clin Infect Dis 2012; 54: 1126-33.
13. Fujitani S, Yu VL,. A new category-healthcare-associated pneumonia: a good idea, but problems with its execution. Eur J Clin Microbiol Infect Dis 2006; 25: 627-31.
14. Wunderink RG,. Healthcare-associated bacteremia: stirring the mud. Crit Care Med 2006; 34: 2685-6.
15. Kollef MH, Morrow LE, Baughman RP, et al., Health-care associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes-Proceedings of the HCAP summit. Clin Infect Dis 2008; 46 (Suppl 4): S296-334.
16. Brito V, Niederman MS,. Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia. Curr Opin Infect Dis 2009; 22: 316-25.
17. Maruyama T, Fujisawa T, Okuno M, et al., A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug resistant pathogens to select initial empiric therapy. Clin Infect Dis 2013; 57: 1373-83.
18. Shorr AF, Zilberberg MD, Micek ST, Kollef MH,. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. Arch Intern Med 2008; 168: 2205-10.
19. Shorr AF, Zilberberg MD, Reichley R, et al., Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. Clin Infect Dis 2012; 54: 193-8.
20. Aliberti S, Di Pasquale M, Zanaboni AM, et al., Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. Clin Infect Dis 2012; 54: 470-8.
21. Shindo Y, Ryota I, Kobayashi D, et al., Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. Am J Respir Crit Care Med 2013; 188: 985-95.
22. Gilbert EH, Lowenstein SR, Koziol-McLain J, Barta DC, Steiner J,. Chart reviews in emergency medicine research: where are the methods. Ann Emerg Med 1996; 27: 305-8.
23. Wunderink RG,. Community-acquired pneumonia versus healthcare-associated pneumonia: the returning pendulum. Am J Respir Crit Care Med 2013; 188: 896-8.
24. Bartlett JG, Ryan KJ, Smith TF, Wilson WR,. Laboratory diagnosis of lower respiratory tract infections. in:, Washington JA, ed. Cumitech 7A. Washington, DC: American Society for Microbiology, 1978.
25. BD Phoenix Laboratory Procedure. Available at: https://www.bd.com/ds/technicalCenter/clsi/clsi-Phoenix-GramNegative-V5.15-V4.31.pdf. Accessed Mar 13, 2015.
26. Fine MJ, Auble TE, Yealy DM, et al., A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-50.
27. Landis JR, Koch CG,. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74.
28. Chalmers JD, Rother C, Salih W, Ewig S,. Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis. Clin Infect Dis 2014; 58: 330-9.
29. Deeks JJ, Altman DG,. Diagnostic tests 4: likelihood ratios. BMJ 2004; 329: 168-9.
30. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG,. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42: 377-81.
31. Flahault A, Cadilhac M, Thomas G,. Sample size calculation should be performed for design accuracy in diagnostic test studies. J Clin Epidemiol 2005; 58: 859-62.
32. Schreiber MP, Chan CM, Shorr AF,. Resistant pathogens in nonnosocomial pneumonia and respiratory failure. Chest 2010; 137: 1283-8.
33. Kollef MH, Sherman G, Ward S, Fraser VJ,. Inadequate antimicrobial treatment of infections: a major factor for hospital mortality among critically ill patients. Chest 1999; 115: 462-74.
34. Moehring RW, Sloane R, Chen LF, et al., Delays in appropriate antibiotic therapy for gram-negative bloodstream infections: a multicenter, community hospital study. PLoS One 2013; 8: e76225.
35. Chen HC, Lin WL, Lin CC, et al., Outcome of inadequate empirical antibiotic therapy in emergency department patients with community-onset bloodstream infections. J Antimicrob Chemother 2013; 68: 947-53.
36. Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D,. Inappropriate initial antibiotic therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003; 155: 529-35.
37. Kett DH, Cano E, Quartin AA, et al., Implementation of guidelines for management of possible multidrug resistant pneumonia in intensive care: an observational, multicenter cohort study. Lancet Infect Dis 2011; 11: 181-9.
38. Paul M, Benuri-Silbiger I, Soares-Weiser K, Leibovici L,. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: a systematic review and meta-analysis of randomized trials. BMJ 2004; 328: 668.
39. Kelly CP, Pothoulakis C, LaMont JT,. Clostridium difficile colitis. N Engl J Med 1994; 330: 257-62.
40. Arias CA, Murray BE,. Antibiotic-resistant bugs in the 21st Century-a clinical super-challenge. N Engl J Med 2009; 360: 439-43.
41. Graffunder EM, Venezia RA,. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 2002; 49: 999-1005.
42. Stevenson KB, Balada-Llasat JM, Bauer K, et al., The economics of antimicrobial stewardship: the current state of the art and applying the business case model. Infect Control Hosp Epidemiol 2012; 33: 389-97.
43. Attridge RT, Frei CR, Restrepo MI, et al., Guideline-concordant therapy and outcomes in healthcare-associated pneumonia. Eur Respir J 2011; 38: 878-87.
44. Caliendo AM, Gilbert DN, Cinocchio CC, et al., Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis 2013; 57 (Suppl 3): S139-70.
45. Restrepo MI, Aliberti S,. Healthcare-associated pneumonia: where do we go next? Clin Infect Dis 2014; 58: 340-1.